 | |
| Type | Private |
|---|---|
| Industry | Medical Technology |
| Founded | 2004 |
| Founders | Dr. Danny Lange, Yossi Gross, Avner Halperin |
| Headquarters | |
Area served | Worldwide |
Key people | Matt Johnson (CEO) |
| Website | earlysense |
EarlySense was an Israeli medical device company with offices in the United States. It has sold its proprietary contact-free continuous monitoring technology to Hill-rom, now Baxter International.
The company was founded in 2004 by Dr. Danny Lange, Yossi Gross, and Avner Halperin. The CEO is Matt Johnson. [1]
The product has two components: a sensor that is placed under a mattress and a software application. [2] The company sells a version of the product designed for use in hospitals that received 510K marketing clearance from the FDA in 2009, meaning that it is equivalent to devices already on the market. [3] [4] [2] It also received the CE mark in Europe. [3] In this system, the sensor measures changes in pressure applied to it through the mattress, and transmits the measurements to the software, which converts them to heart rate, breathing rate, and motion. The application can be used by nurses to monitor patients in their ward remotely; it can provide alerts if patients try to get out of bed, and can provide alerts that a patient needs to be turned in order to avoid the development of pressure ulcers. [2]
In September 2015 the company launched a version of the product for people to use at home to monitor their sleep; in this system the desktop application is replaced by a smartphone app. [5] EarlySense also provided OEM services to other companies that market the system under their own brands. [6]
The company also offers contact-free continuous monitoring (CFCM) sensors for use in healthcare settings. The sensors allow wireless monitoring of patients. [1]
Telemetry is the in situ collection of measurements or other data at remote points and their automatic transmission to receiving equipment (telecommunication) for monitoring. The word is derived from the Greek roots tele, 'remote', and metron, 'measure'. Systems that need external instructions and data to operate require the counterpart of telemetry: telecommand.
A security alarm is a system designed to detect intrusions, such as unauthorized entry, into a building or other areas, such as a home or school. Security alarms protect against burglary (theft) or property damage, as well as against intruders. Examples include personal systems, neighborhood security alerts, car alarms, and prisons.
A medical device is any device intended to be used for medical purposes. Significant potential for hazards are inherent when using a device for medical purposes and thus medical devices must be proved safe and effective with reasonable assurance before regulating governments allow marketing of the device in their country. As a general rule, as the associated risk of the device increases the amount of testing required to establish safety and efficacy also increases. Further, as associated risk increases the potential benefit to the patient must also increase.
A glucose meter, also referred to as a "glucometer", is a medical device for determining the approximate concentration of glucose in the blood. It can also be a strip of glucose paper dipped into a substance and measured to the glucose chart. It is a key element of glucose testing, including home blood glucose monitoring (HBGM) performed by people with diabetes mellitus or hypoglycemia. A small drop of blood, obtained from slightly piercing a fingertip with a lancet, is placed on a disposable test strip that the meter reads and uses to calculate the blood glucose level. The meter then displays the level in units of mg/dL or mmol/L.
Fullpower is a Santa Cruz, California-based privately held developer of cloud-based IoT and wearable product technology used for activity tracking and sleep monitoring. Fullpower specializes in wireless technology, microelectromechanical systems, and nanotechnology. The company holds over 125 patents for its intellectual property, which it licenses to manufacturers.
Automated insulin delivery systems are automated systems designed to assist people with insulin-requiring diabetes, by automatically adjusting insulin delivery in response to blood glucose levels. Currently available systems can only deliver a single hormone—insulin. Other systems currently in development aim to improve on current systems by adding one or more additional hormones that can be delivered as needed, providing something closer to the endocrine functionality of the pancreas.
Wearable technology is any technology that is designed to be used while worn. Common types of wearable technology include smartwatches and smartglasses. Wearable electronic devices are often close to or on the surface of the skin, where they detect, analyze, and transmit information such as vital signs, and/or ambient data and which allow in some cases immediate biofeedback to the wearer.
DexCom, Inc. is a company that develops, manufactures, produces, and distributes continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with headquarters in San Diego, California, and has manufacturing facilities in Mesa, Arizona and Batu Kawan, Malaysia.
Wireless health is the integration of wireless technology into traditional medicine, such as diagnosis, monitoring and treatment of illness, as well as other tools that can help individuals improve their personal health and wellbeing. Wireless health differs from mHealth in that wireless health solutions will not always be mobile and mobile health solutions will not always be wirelessly enabled. Mobile broadband connectivity is useful in reaching new patients in remote areas while improving productivity and convenience through data transmission.
In medicine, monitoring is the observation of a disease, condition or one or several medical parameters over time.
Remote patient monitoring (RPM) is a technology to enable monitoring of patients outside of conventional clinical settings, such as in the home or in a remote area, which may increase access to care and decrease healthcare delivery costs. RPM involves the constant remote care of patients by their physicians, often to track physical symptoms, chronic conditions, or post-hospitalization rehab.
A body area network (BAN), also referred to as a wireless body area network (WBAN) or a body sensor network (BSN) or a medical body area network (MBAN), is a wireless network of wearable computing devices. BAN devices may be embedded inside the body as implants or pills, may be surface-mounted on the body in a fixed position, or may be accompanied devices which humans can carry in different positions, such as in clothes pockets, by hand, or in various bags. While there is a trend toward the miniaturization of devices, in particular body area networks which consist of several miniaturized body sensor units (BSUs) together with a single body central unit (BCU), larger decimeter sized smart devices still play an important role in terms of acting as a data hub or data gateway and providing a user interface to view and manage BAN applications, in-situ. The development of WBAN technology started around 1995 around the idea of using wireless personal area network (WPAN) technologies to implement communications on, near, and around the human body. About six years later, the term "BAN" came to refer to systems where communication is entirely within, on, and in the immediate proximity of a human body. A WBAN system can use WPAN wireless technologies as gateways to reach longer ranges. Through gateway devices, it is possible to connect the wearable devices on the human body to the internet. This way, medical professionals can access patient data online using the internet independent of the patient location.
BodyMedia was a medical and consumer technology company headquartered in Pittsburgh, Pennsylvania. Incorporated in 1999, BodyMedia developed wearable body monitoring systems. In April 2013, BodyMedia was acquired by Jawbone for an estimated $100 million.
An activity tracker, also known as a fitness tracker, is a device or application for monitoring and tracking fitness-related metrics such as distance walked or run, calorie consumption, and in some cases heartbeat. It is a type of wearable computer. The term is now primarily used for smartwatches that are synced, in many cases wirelessly, to a computer or smartphone for long-term data tracking. There are also independent mobile and Facebook apps. Some evidence has found that the use of these type of devices results in less weight loss rather than more. Sleep tracker devices have a tendency to underdetect wakefulness.
Google Contact Lens was a smart contact lens project announced by Google on 16 January 2014. The project aimed to assist people with diabetes by constantly measuring the glucose levels in their tears. The project was being carried out by Verily and as of 2014 was being tested using prototypes. On November 16, 2018, Verily announced it had discontinued the project.
A continuous glucose monitor (CGM) is a device used for monitoring blood glucose on a continual basis by insulin-requiring people with diabetes, e.g. people with type I, type II diabetes or other types of diabetes. A continuous glucose monitor consists of three parts: a small electrode placed under the skin, a transmitter sending readings at regular intervals, and a separate receiver. Currently approved CGMs use an enzymatic technology which reacts with glucose molecules in the interstitial fluid generating an electric current. This electric current is then relayed from a transmitter attached to the sensor out to a reader which displays the data to the patient.
AliveCor is a medical device and AI company producing ECG hardware and software for consumer mobile devices. The company was the first to receive FDA-clearance for a medical-device accessory to the Apple Watch. The company's primary product is the AliveCor KardiaMobile, a portable ECG device that can be used to detect atrial fibrillation (AFib) and other cardiac conditions. AliveCor was founded in 2010 and is headquartered in Mountain View, California, the United States.
CardiacSense is a developer of a wearable technology for continuous cardiac arrhythmia detection and vital signs monitoring. CardiacSense is based in Caesarea, Israel.
Empatica Inc. is an MIT Media Lab spinoff company born in Cambridge, Massachusetts, operating in Healthcare, providing AI-enabled tools to advance forecasting, monitoring, research, and treatment. Empatica produces medical-grade wearables, software and algorithms for the collection and interpretation of physiological data. Empatica's wearables, Embrace2 and E4, track physiological signals such as Heart Rate Variability, electrodermal activity, acceleration and movement, skin temperature, and autonomic arousal. Embrace2 has been cleared by the FDA as a seizure alerting solution for epilepsy patients with generalized tonic-clonic seizures. The E4 is used by researchers for real-time physiological data capture. The company is headquartered in Boston, MA with offices in Milan, Italy, and Seoul, South Korea.
Develco Products is a B2B wireless technology producer, headquartered in Aarhus, Denmark. The company was established in 2007 and develops white label devices for B2C solution providers and has over 3,000,000 devices deployed worldwide... Their main business areas are home care, security, InsurTech, and smart energy. They are a member of the Connectivity Standards Alliance as their main technological expertise lies in Zigbee-based devices that communicate through a mesh network. The company claims their most popular product is the Squid.link gateway.
{{cite journal}}: Cite journal requires |journal= (help)